$14.24
-0.22-1.52%
Last update: Nov 9, 4:00 PM
BlossomHill Therapeutics Inc
BLSMNASDAQ
The average analyst price target for BlossomHill Therapeutics is $34.17, 136.3% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $28 to $40. The latest change came on Sep 21, 2026, when Leerink Partners raised its price target on BlossomHill Therapeutics from $36 to $40 and kept an Outperform rating.
Price Target Range — 1 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
